This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
AbCellera Biologics Inc.
Q22022
8/9/2022
Lydia
Call Facilitator / Conference Call Operator
Welcome to Abcelera's second quarter 2022 business update and conference call. My name is Lydia, and I'll facilitate the audio portion of today's interactive broadcast. If you'd like to ask a question after the prepared remark, please press start, followed by the number one on your telephone keypad. At this time, Steema, Abcelera's Chief Legal and Compliance Officer.
Dr. Carl Hansen
Chief Executive Officer and President
Thank you. Good afternoon, 22 Business Update.
Andrew Booth
Chief Financial Officer
We're pleased to have you with us today for a press release issued after the market closed today, which you can find on our Investor Relations website.
You're reading a preview of the ABCL Q2 2022 earnings call.
Free account.
Disclaimer